SUSAN K PETERSON to Ovarian Neoplasms
This is a "connection" page, showing publications SUSAN K PETERSON has written about Ovarian Neoplasms.
Connection Strength
0.734
-
Uptake of cancer risk management strategies among women who undergo cascade genetic testing for breast cancer susceptibility genes. Cancer. 2021 10 01; 127(19):3605-3613.
Score: 0.246
-
Long-Term Adaptation Among Adolescent and Young Adult Children to Familial Cancer Risk. Pediatrics. 2022 08 01; 150(2).
Score: 0.067
-
Increasing referral of at-risk women for genetic counseling and BRCA testing using a screening tool in a community breast imaging center. Cancer. 2022 Jan 01; 128(1):94-102.
Score: 0.062
-
Factors Influencing Discussion of Cancer Genetic Testing with Health-Care Providers in a Population-Based Survey. Public Health Genomics. 2021; 24(3-4):160-170.
Score: 0.061
-
Clinical management among individuals with variant of uncertain significance in hereditary cancer: A systematic review and meta-analysis. Clin Genet. 2021 08; 100(2):119-131.
Score: 0.061
-
Cancer genetic health communication in families tested for hereditary breast/ovarian cancer risk: a qualitative investigation of impact on children's genetic health literacy and psychosocial adjustment. Transl Behav Med. 2019 05 16; 9(3):493-503.
Score: 0.053
-
Cancer screening behaviors and risk perceptions among family members of colorectal cancer patients with unexplained mismatch repair deficiency. Fam Cancer. 2017 04; 16(2):231-237.
Score: 0.046
-
Satisfaction with ovarian carcinoma risk-reduction strategies among women at high risk for breast and ovarian carcinoma. Cancer. 2011 Jun 15; 117(12):2659-67.
Score: 0.030
-
Obstetrics/gynecology residents' knowledge of hereditary breast and ovarian cancer and Lynch syndrome. J Cancer Educ. 2010 Sep; 25(3):401-4.
Score: 0.029
-
Cost-effectiveness analysis of prevention strategies for gynecologic cancers in Lynch syndrome. Cancer. 2008 Jul 15; 113(2):326-35.
Score: 0.025
-
Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study. Cancer. 2006 Dec 15; 107(12):2745-51.
Score: 0.023
-
Prophylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutations. Obstet Gynecol. 2006 Sep; 108(3 Pt 1):515-20.
Score: 0.022
-
Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian. Cancer. 2015 Jan 15; 121(2):269-75.
Score: 0.010